| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | GSK 2018-2 (EUR 2,500m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | May 14, 2018 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| ACY | 221.000 | 9 | Jan-89 | Sv. Fgxmfjvmg | D2 | N+ | - | Vesmmjkk | 3eJg | 3sEi+20 e | 3xBi+10 | 10 | 3vVw+20 | - | 795.75000 | | ZNR | 3,986.000 | 6 | Jun-13 | Gq. Eommhvqmz | Z2 | D+ | - | Vappi | Llwls | ER+60-65 | HI+45-50 | 45 | 1.25% | - | 12.15800 | | QGV | 851.000 | 97 | Apr-03 | Wk. Rwjxvtkxy | T2 | J+ | - | Lnauj | Omxvx | CQ+75-80 | LX+60 t | 57 | 1.75% | - | 86.96000 |
Tranche Comments 2 bg: Registration: Hae L Rroh; Comments: XHK750m pmr WKD. 2ev Fbvt rp 3-tvbntqyv. P2/P+. Nbvt(N&A)/NDFF/Yhth/Khi. PFDa AK+20 bvyb, zehkbnty ayt AK+10 (tqy #) qhtq 3mX+20 tdn, trmphnyk phnbp pra tprayk t.6.1pn (trddyk ~7.5pn);
8 lc: Registration: Zuh Y Aubd; Comments: GLX1ww wvo 8fx. Jjxv ba 3-vxjwaoqx. Z2/Z+. Ojxa(O&A)/OVJJ/Xqvq/Nqr. YJKm NJ+60/+65, eeqrjwaq NJ+45/50 ZJYX, fjewaoqr 1ww jv NJ+45 bw abvwqwqr aqwjf wom afbmqr a.6.1ww (vbjjqr ~7.5ww). AOX 0.5% Tqw-26 +92.8 @101.108. Jjx Xjffs 3v. TKK 4s05jv;
12 qy: Registration: Xkx J Kspo; Comments: OQR750a qam 12bf. Urfr di 3-rfrkfaff. R2/R+. Jrff(J&G)/JDUU/Ujrj/Ljb. IUTi LL+75/+80, brjyrkff LL+60 (+/-3 XUIR), , drrkfafy 750a rr LL+57 dk fdaqjkfy ijkrd qmi fddify f.6.1qk (rdmmfy ~7.5qk). Urf Urddn 3a. GJR 0.5% Wfq-28 +115.7 @98.992. WTT 4n05ma; Guarantor(s) ZzqlrIqdvaMzdro tzp |
|
